BlackRock Fund Advisors - TRANSCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$90,000
-5.3%
44,578
-6.8%
0.00%
Q2 2014$95,000
-33.6%
47,825
+2.9%
0.00%
Q1 2014$143,000
+4.4%
46,457
+13.8%
0.00%
Q4 2013$137,000
+10.5%
40,814
+4.4%
0.00%
Q3 2013$124,000
+13.8%
39,104
+8.5%
0.00%
Q2 2013$109,00036,0260.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,255,691$7,173,0005.84%
NEA Management Company, LLC 2,086,755$6,636,0000.26%
TOURADJI CAPITAL MANAGEMENT, LP 10,000$32,0000.10%
Loeb Offshore Management LP 101,000$321,0000.10%
BVF INC/IL 150,000$477,0000.08%
ABNER HERRMAN & BROCK LLC 20,000$64,0000.04%
SABBY MANAGEMENT, LLC 173,500$552,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 67,000$213,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 52,000$165,0000.00%
PANAGORA ASSET MANAGEMENT INC 96,858$307,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders